View of 967 – Tumor-infiltrating lymphocytes predict pathologic complete response in human epidermal growth factor receptor 2 (HER2)-positive breast cancer treated with neoadjuvant therapy

Return to Article Details 967 – Tumor-infiltrating lymphocytes predict pathologic complete response in human epidermal growth factor receptor 2 (HER2)-positive breast cancer treated with neoadjuvant therapy Download Download PDF